vs

Side-by-side financial comparison of EPAM Systems (EPAM) and Organon & Co. (OGN). Click either name above to swap in a different company.

Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× EPAM Systems). EPAM Systems runs the higher net margin — 7.8% vs -13.6%, a 21.4% gap on every dollar of revenue. On growth, EPAM Systems posted the faster year-over-year revenue change (12.8% vs -5.3%). EPAM Systems produced more free cash flow last quarter ($268.1M vs $96.0M). Over the past eight quarters, EPAM Systems's revenue compounded faster (9.9% CAGR vs -3.6%).

EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

EPAM vs OGN — Head-to-Head

Bigger by revenue
OGN
OGN
1.1× larger
OGN
$1.5B
$1.4B
EPAM
Growing faster (revenue YoY)
EPAM
EPAM
+18.1% gap
EPAM
12.8%
-5.3%
OGN
Higher net margin
EPAM
EPAM
21.4% more per $
EPAM
7.8%
-13.6%
OGN
More free cash flow
EPAM
EPAM
$172.1M more FCF
EPAM
$268.1M
$96.0M
OGN
Faster 2-yr revenue CAGR
EPAM
EPAM
Annualised
EPAM
9.9%
-3.6%
OGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EPAM
EPAM
OGN
OGN
Revenue
$1.4B
$1.5B
Net Profit
$109.4M
$-205.0M
Gross Margin
30.1%
49.2%
Operating Margin
10.6%
-9.8%
Net Margin
7.8%
-13.6%
Revenue YoY
12.8%
-5.3%
Net Profit YoY
5.9%
-288.1%
EPS (diluted)
$1.97
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPAM
EPAM
OGN
OGN
Q4 25
$1.4B
$1.5B
Q3 25
$1.4B
$1.6B
Q2 25
$1.4B
$1.6B
Q1 25
$1.3B
$1.5B
Q4 24
$1.2B
$1.6B
Q3 24
$1.2B
$1.6B
Q2 24
$1.1B
$1.6B
Q1 24
$1.2B
$1.6B
Net Profit
EPAM
EPAM
OGN
OGN
Q4 25
$109.4M
$-205.0M
Q3 25
$106.8M
$160.0M
Q2 25
$88.0M
$145.0M
Q1 25
$73.5M
$87.0M
Q4 24
$103.3M
$109.0M
Q3 24
$136.3M
$359.0M
Q2 24
$98.6M
$195.0M
Q1 24
$116.2M
$201.0M
Gross Margin
EPAM
EPAM
OGN
OGN
Q4 25
30.1%
49.2%
Q3 25
29.5%
53.5%
Q2 25
28.8%
54.8%
Q1 25
26.9%
55.6%
Q4 24
30.4%
56.3%
Q3 24
34.6%
58.3%
Q2 24
29.3%
58.4%
Q1 24
28.4%
59.0%
Operating Margin
EPAM
EPAM
OGN
OGN
Q4 25
10.6%
-9.8%
Q3 25
10.4%
15.2%
Q2 25
9.3%
14.4%
Q1 25
7.6%
6.7%
Q4 24
10.9%
8.1%
Q3 24
15.2%
13.1%
Q2 24
10.5%
14.6%
Q1 24
9.5%
14.5%
Net Margin
EPAM
EPAM
OGN
OGN
Q4 25
7.8%
-13.6%
Q3 25
7.7%
10.0%
Q2 25
6.5%
9.1%
Q1 25
5.6%
5.8%
Q4 24
8.3%
6.8%
Q3 24
11.7%
22.7%
Q2 24
8.6%
12.1%
Q1 24
10.0%
12.4%
EPS (diluted)
EPAM
EPAM
OGN
OGN
Q4 25
$1.97
$-0.78
Q3 25
$1.91
$0.61
Q2 25
$1.56
$0.56
Q1 25
$1.28
$0.33
Q4 24
$1.80
$0.42
Q3 24
$2.37
$1.38
Q2 24
$1.70
$0.75
Q1 24
$1.97
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPAM
EPAM
OGN
OGN
Cash + ST InvestmentsLiquidity on hand
$1.3B
$574.0M
Total DebtLower is stronger
$8.6B
Stockholders' EquityBook value
$3.7B
$752.0M
Total Assets
$4.9B
$12.9B
Debt / EquityLower = less leverage
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPAM
EPAM
OGN
OGN
Q4 25
$1.3B
$574.0M
Q3 25
$1.2B
$672.0M
Q2 25
$1.0B
$599.0M
Q1 25
$1.2B
$547.0M
Q4 24
$1.3B
$675.0M
Q3 24
$2.1B
$763.0M
Q2 24
$1.8B
$704.0M
Q1 24
$2.0B
$575.0M
Total Debt
EPAM
EPAM
OGN
OGN
Q4 25
$8.6B
Q3 25
$8.8B
Q2 25
$8.9B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Q1 24
$8.7B
Stockholders' Equity
EPAM
EPAM
OGN
OGN
Q4 25
$3.7B
$752.0M
Q3 25
$3.7B
$906.0M
Q2 25
$3.7B
$733.0M
Q1 25
$3.6B
$542.0M
Q4 24
$3.6B
$472.0M
Q3 24
$3.6B
$493.0M
Q2 24
$3.4B
$144.0M
Q1 24
$3.5B
$48.0M
Total Assets
EPAM
EPAM
OGN
OGN
Q4 25
$4.9B
$12.9B
Q3 25
$4.8B
$13.6B
Q2 25
$4.7B
$13.5B
Q1 25
$4.7B
$13.2B
Q4 24
$4.8B
$13.1B
Q3 24
$4.5B
$12.8B
Q2 24
$4.2B
$12.2B
Q1 24
$4.4B
$11.9B
Debt / Equity
EPAM
EPAM
OGN
OGN
Q4 25
11.49×
Q3 25
9.74×
Q2 25
12.14×
Q1 25
16.52×
Q4 24
18.81×
Q3 24
17.75×
Q2 24
60.11×
Q1 24
181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPAM
EPAM
OGN
OGN
Operating Cash FlowLast quarter
$282.9M
$141.0M
Free Cash FlowOCF − Capex
$268.1M
$96.0M
FCF MarginFCF / Revenue
19.0%
6.4%
Capex IntensityCapex / Revenue
1.1%
3.0%
Cash ConversionOCF / Net Profit
2.59×
TTM Free Cash FlowTrailing 4 quarters
$612.7M
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPAM
EPAM
OGN
OGN
Q4 25
$282.9M
$141.0M
Q3 25
$294.7M
$264.0M
Q2 25
$53.2M
$220.0M
Q1 25
$24.2M
$75.0M
Q4 24
$130.3M
$390.0M
Q3 24
$242.0M
$141.0M
Q2 24
$57.0M
$332.0M
Q1 24
$129.9M
$76.0M
Free Cash Flow
EPAM
EPAM
OGN
OGN
Q4 25
$268.1M
$96.0M
Q3 25
$286.4M
$218.0M
Q2 25
$43.4M
$181.0M
Q1 25
$14.8M
$43.0M
Q4 24
$114.5M
$335.0M
Q3 24
$237.0M
$99.0M
Q2 24
$52.3M
$300.0M
Q1 24
$123.2M
$30.0M
FCF Margin
EPAM
EPAM
OGN
OGN
Q4 25
19.0%
6.4%
Q3 25
20.5%
13.6%
Q2 25
3.2%
11.4%
Q1 25
1.1%
2.8%
Q4 24
9.2%
21.0%
Q3 24
20.3%
6.3%
Q2 24
4.6%
18.7%
Q1 24
10.6%
1.8%
Capex Intensity
EPAM
EPAM
OGN
OGN
Q4 25
1.1%
3.0%
Q3 25
0.6%
2.9%
Q2 25
0.7%
2.4%
Q1 25
0.7%
2.1%
Q4 24
1.3%
3.5%
Q3 24
0.4%
2.7%
Q2 24
0.4%
2.0%
Q1 24
0.6%
2.8%
Cash Conversion
EPAM
EPAM
OGN
OGN
Q4 25
2.59×
Q3 25
2.76×
1.65×
Q2 25
0.60×
1.52×
Q1 25
0.33×
0.86×
Q4 24
1.26×
3.58×
Q3 24
1.77×
0.39×
Q2 24
0.58×
1.70×
Q1 24
1.12×
0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons